Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health (NYSE: CVS) has announced that Shawn Guertin, Executive Vice President and Chief Financial Officer, will speak at the Barclays Global Healthcare Conference on March 15, 2022, at approximately 8:00 am ET. An audio webcast of this event will be available live on the CVS Health Investor Relations website, with an archive available for one year.
CVS Health is a leader in health solutions, dedicated to enhancing community health through various services and support.
Summary not available.
CVS Health (NYSE: CVS) has launched a new digital service allowing consumers to order at-home COVID-19 test kits with zero upfront costs. This service simplifies the process by enabling consumers to enter their insurance details online, with CVS handling all claims. Notifications regarding order status will be sent via email or text. Following recent federal guidance effective January 15, 2022, insurers must cover up to eight tests per person per month. In 2021, CVS sold 22 million test kits and administered over 59 million COVID-19 vaccines.
CVS Health Corporation reported strong financial results for Q4 and full-year 2021, with total revenues reaching $76.6 billion for Q4 and $292.1 billion for the year, marking increases of 10.1% and 8.7% respectively. GAAP diluted EPS was $0.98 in Q4 and $5.95 for the year. Adjusted EPS rose to $1.98 for Q4 and $8.40 for the full year. The company also confirmed guidance for 2022, projecting GAAP EPS between $7.04 and $7.24.
CVS continued its pandemic response, administering over 59 million COVID-19 vaccines. A 10% increase in the annual dividend and a $10 billion share repurchase program were announced.
CVS Health has partnered with Medable to enhance patient access and engagement in clinical trials at select MinuteClinic locations. This collaboration aims to address low participation rates in clinical studies, particularly among underrepresented groups. Medable's software platform will facilitate decentralized clinical trial delivery and real-world evidence generation. CVS Health aims to leverage its extensive community reach to improve patient outcomes and support diversity in clinical research.
CVS Health has announced a significant investment of $12.7 million in partnership with R4 Capital to construct 204 affordable housing units in Nashville's Chestnut Hill neighborhood. This initiative aims to tackle racial inequity and health determinants by providing affordable housing for families earning 30% - 70% of the Area Median Income. The housing development, named 101 Factory, will feature various amenities and services aimed at enhancing residents' health and well-being. CVS Health has a broader commitment, having invested $185 million in affordable housing nationwide in 2021.
CVS Health has announced a $6.5 million investment to create Charity's House Place, a 36-unit supportive housing community in Denver aimed at aiding individuals experiencing homelessness and those with disabilities. This initiative reflects CVS's commitment to health equity, addressing social determinants of health in underserved areas. The project will collaborate with local organizations to provide essential services, ensuring residents can maintain stable housing and improve their health. In 2021, CVS invested $185 million in affordable housing, underscoring its ongoing dedication to community support.
CVS Health announced a collaboration with Uber Health to provide free transportation support for individuals needing access to medical care, work, or educational programs. This partnership is part of CVS's Health Zones initiative aimed at reducing health disparities in high-risk communities, beginning in cities like Atlanta, Columbus, and Hartford. The initiative focuses on social determinants of health, including transportation. CVS Health has invested $185 million in affordable housing and $1.3 billion over 20 years to improve health equity across America.
CVS Health (NYSE: CVS) announce a conference call on February 9, 2022, at 8:00 a.m. ET to discuss its fourth quarter and full year 2021 financial results. The call will be accessible via an audio webcast on the CVS Health Investor Relations website. CVS is a leading health solutions company, improving community health through 300,000 dedicated colleagues, including 40,000 physicians. The company emphasizes affordable health services and care management, aiming to enhance access and lower costs for consumers.
CVS Health announced that President and CEO Karen S. Lynch and CFO Shawn Guertin will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at approximately 8:15 am ET. This presentation underscores CVS's commitment to delivering comprehensive health solutions across America, with approximately 300,000 colleagues including over 40,000 healthcare professionals. The conference is a significant event in the healthcare sector, providing insights into CVS's strategic direction and initiatives.